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ABSTRACT
Aim.  To examine whether exercise counselling increases smoking abstinence and 
reduces tobacco withdrawal and gains in weight and body fat. Design. A randomised 
controlled trial. Setting. A community-based stop smoking clinic. Participants. 299 
male and female smokers. Intervention. Participants were randomly assigned to a 
seven week smoking cessation programme including nicotine replacement therapy 
plus either (i) exercise counselling, or (ii) health education advice with equal contact 
time as for the exercise counselling condition. Measurements. Six weeks of smoking 
abstinence was confirmed by expired carbon monoxide,. Findings. There was no 
significant difference in smoking abstinence between the exercise group (n=154) and 
the controls (n=145) at six weeks (39.6% versus 38.6%). Nor was there any difference 
in gains in weight or body fat, although those in the exercise group increased their 
exercise levels. Exercise participants reported less tension, anxiety and stress, and 
more happiness than the controls during the first week of smoking abstinence (P=.03, 
.01, .04, .03, respectively); less irritability through two weeks of abstinence (P=.03), 
and less restlessness through three weeks of abstinence (P=.04). Conclusions. Adding 
brief exercise counselling to a smoking cessation programme did not significantly 
increase smoking abstinence or reduce gains in weight or body fat, although exercise 
levels were raised and there were some beneficial effects on psychological symptoms. 
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Cigarette smoking is a leading cause of premature death in industrialised countries (1) 
and smoking cessation extends life and reduces morbidity (2). A combination of 
behavioural support and nicotine replacement therapy (NRT) has been shown to be 
one of the most effective smoking cessation interventions, achieving abstinence rates 
at twelve months of approximately 15-20% (3). Additional interventions are needed in 
order to increase these success rates.
There is some evidence to suggest that exercise may be useful as an aid to 
smoking cessation (4). Of eight previous studies examining the efficacy of supervised,
vigorous intensity exercise as an adjunct to a behaviourally-based smoking cessation 
programme three have found a significant benefit for those receiving an exercise 
programme (4). One of these studies examined the effect of thrice weekly sessions of 
vigorous (70-85% of maximal heart rate) supervised aerobic exercise, lasting 30-45 
minutes, on smoking abstinence in 20 female smokers (5). Following seven days of 
smoking abstinence significantly more of the exercise group remained abstinent when 
compared with a control group receiving only behavioural support. A second study 
examined the effect of four weeks of weekly vigorous (60-75% of maximal heart rate) 
supervised exercise sessions lasting 15-45 minutes, plus three similar exercise 
sessions at home, on smoking rates in 205 male and female smokers recovering from 
an alcohol problem (6). At the end of treatment, but not after six or twelve months, 
rates of smoking abstinence were significantly higher for a group combining exercise 
and behavioural support than for those receiving nicotine gum and behavioural 
support, or having a standard smoking cessation treatment; although these results may 
not be generalizable beyond smokers with alcohol problems. The most methodologically rigorous study to date investigated the effect of 12 
weeks of thrice weekly vigorous (60-85% of heart rate reserve) supervised aerobic 
exercise, lasting 30-40 minutes, on smoking abstinence in 281 female smokers (7). 
Twelve months following treatment those in the exercise condition achieved 
approximately double the smoking abstinence rates of those in an equal contact 
control condition. In addition, those in the exercise condition gained significantly less 
weight at the end of treatment (7); and reported significantly less tobacco withdrawal 
symptoms, negative affect and cravings for cigarettes immediately following exercise 
during nine weeks of the treatment (8). Other studies confirm that exercise has an 
acute moderating effect on tobacco withdrawal and urges to smoke (9) and results in a 
reduction in post-smoking cessation weight gain (10). The five studies finding no 
effect of an exercise intervention on smoking abstinence had various methodological 
limitations; including, a small sample size and an inadequate smoking cessation 
programme or control condition (4).
In practice, the intensive exercise regimens adopted in previous studies of exercise 
and smoking cessation, focusing on supervised and structured vigorous exercise, are 
probably beyond the scope of many smoking cessation services, and are likely to be 
less cost-effective than interventions emphasising independent  and ‘lifestyle’ type 
exercise (11). Furthermore, current physical activity recommendations encompass 
short, intermittent and daily bouts of moderate intensity exercise and encourage 
tailored regimens, including routine ‘lifestyle’ activities such as walking (12). In 
addition, there is some evidence to suggest that a counselling based intervention 
promoting lifestyle type exercise can result in comparable increases in exercise as for 
a more structured and supervised exercise intervention (13). Consequently, the present 
study adopted a more public health oriented approach than used in previous studies of exercise and smoking cessation through promoting exercise with exercise counselling 
alone. A randomized controlled trial was conducted to examine whether adding brief 
exercise counselling to a smoking cessation treatment programme including could 
increase rates of smoking abstinence and reduce post-cessation weight and body fat 
gain, tobacco withdrawal, and urges to smoke.
METHODS
Participants 
Men and women aged 18 to 65 years, who had been smoking at least 10 cigarettes a 
day for at least three years, were motivated to stop smoking, and had not engaged in 
30 minutes of moderate intensity exercise on five days a week, or 20 minutes of 
vigorous exercise on three days a week during the past three months (12), were 
recruited through newspaper advertisements or referral from their physician. Smokers 
who had a current psychiatric illness or substance misuse problem, were pregnant or 
planning a pregnancy, or who had a medical condition that would make compliance 
with the exercise regimen difficult (14) were excluded. 
Research design 
The study was a randomized controlled trial comparing two conditions: (i) a 
cognitive-behavioral and NRT smoking cessation programme plus brief exercise
counselling (‘exercise’) and (ii) the same smoking cessation programme plus equal 
staff contact time (‘control’). It was necessary to control for exposure time in this 
study in order to separate the effect of the exercise counselling from the effect of 
frequent contact with the investigator. On attendance at their first treatment session 
individual smokers were assigned to either the exercise or the control condition using 
a computer generated list of random numbers (Figure 1). Participants provided written consent and physicians were informed of their patients involvement in the 
study. The ethics committee of St. George’s Hospital gave its' approval.
Treatment regime
Smoking cessation programme
All participants attended six individually-based weekly smoking cessation treatment 
sessions and a follow-up session two weeks after the final treatment. The first session 
took approximately 30 minutes. The other sessions lasted for 15-20 minutes. A 
cognitive-behavioural format was used incorporating self-monitoring, goal-setting, 
preparing for high risk situations, and coping with tobacco withdrawal (15,16). 
Participants were required to stop smoking immediately prior to their second 
treatment session. Two Masters-level smoking cessation counsellors delivered the 
treatment programmes via standardised manuals. 
Nicotine replacement therapy
NRT has been shown to be one of the most effective aids to smoking cessation (3) and 
is routinely recommended by stop smoking services (17). Compliance tends to be 
higher with transdermal nicotine patches compared to other forms of NRT, and 
patches have been shown to be as effective for increasing smoking abstinence as other 
NRT products (18). Therefore, in the current study all smokers were advised to use
15mg 16- hour patches (19,20), following their final cigarette, on a daily basis, 
throughout the treatment programme (3,21). 
Exercise condition
The intention was to use an exercise intervention which could be readily integrated 
into existing behavioural smoking cessation treatments and which could be implemented by personnel who were not exercise specialists. At the first treatment 
session only those in the exercise condition received approximately five minutes of 
cognitive-behavioural exercise counselling incorporating decision balance sheets, 
goal-setting, relapse prevention planning, and self-monitoring (22). The investigators 
received two days of training in exercise counselling (23). Participants were 
encouraged to use exercise as a self-control strategy for reducing cigarette cravings 
and withdrawal (24). From session two onwards exercise levels in the previous week 
were briefly reviewed (one-two minutes) and encouragement was given towards 
maintaining any increases in exercise. 
Participants were advised to progress over the seven weeks of the trial towards 30 
minutes of ‘lifestyle’ (22) or more structured exercise, on at least five days a week, in 
bouts lasting at least five minutes (12). Short bouts of exercise have been found to be 
effective for improving body composition (25) and for reducing tobacco withdrawal 
symptoms and urges to smoke (9). 
In contrast to the previous study showing an effect of exercise on smoking 
abstinence (7) the present study promoted moderate as well as vigorous intensity 
exercise. Moderate intensity exercise has been shown to provide both greater 
psychological benefits (26) and higher adherence rates (27) when compared with 
vigorous intensity exercise; and has been shown to reduce tobacco withdrawal and 
urges to smoke (9). At each session a resting radial pulse was used to prescribe at least 
a moderate intensity of exercise corresponding to 40% of heart-rate reserve (28), and 
the Borg 6-20 scale was used to recommend a Rating of Perceived Exertion of at least 
‘fairly light’ (29). 
Control condition
During the first treatment session only those in the control condition received approximately five minutes of heath education advice relating to healthy eating, fat 
and salt intake, alcohol consumption and stress management, derived from literature 
produced by the British Heart Foundation. A similar programme has been shown to be 
acceptable in previous trials of exercise for smoking cessation (5, 7). As a substitute 
for the self-monitoring used in the exercise group those in the control group 
monitored situations in which they found it difficult not to smoke, and from session 
two onwards these reports were briefly (duration of approximatelyone- two minutes) 
reviewed each week so as to provide equal contact time as for the exercise condition. 
Measures
At the first visit information was gathered relating to age, gender, marital status, 
employment, occupation, ethnicity, years of education, stage of change for exercise 
(30), cigarettes smoked per day, nicotine dependence (31), and expired air carbon 
monoxide (CO) level using a Bedfont Smokerlyzer. All baseline measures were 
administered before the smokers were assigned to a treatment group.
The main outcome analysis and power calculations for the study were based on 
continuous smoking abstinence from the quit date through six weeks. While many 
smokers relapse to smoking after that time, and 12 months of follow up are often 
considered necessary to demonstrate efficacy, the six-week period is used by the US 
Food and Drug Administration when deciding on efficacy of pharmaceutical smoking 
cessation aids. Furthermore, in the absence of short-term follow-up studies it would 
have been premature to mount the size of study required to test efficacy for 12 
months.
Following one week of smoking abstinence, and then on a weekly basis, smokers 
reported whether they had smoked since the previous visit (32). Smoking abstinence 
was verified with expired air CO concentration (cut-off, 10ppm). If a participant smoked even a single puff, or if they failed to attend a treatment or follow-up session 
and an appointment could not be made within 48 hours, they were excluded from the 
programme and were recorded as having lapsed. Those smokers who were excluded 
from the study were offered further smoking cessation support from another clinic, 
although their progress was not monitored. 
At each visit following the quit day participants reported their type and dose of 
NRT, and reported their weekly urges to smoke on six-point scales in response to 
three items (33): ‘How difficult has it been to stop yourself smoking in the past
week?’ (0=not at all difficult to 5=extremely difficult), ‘How much of the time have 
you felt the urge to smoke in the past week?’ (0=not at all to 5=all the time), and 
‘How strong have the urges been?’ (0=no urges to 5=extremely strong). Urges to 
smoke are generally strongest in the first week of abstinence (34). Therefore on each 
day during the first week of abstinence participants responded on a six-point scale to 
the question ‘How strong is your desire to smoke?’ (35, 0=no urges to 5=extremely 
strong). 
Tobacco withdrawal symptoms were reported by the participants at the first visit 
and then at each visit following the quit day using the Mood and Physical Symptoms 
Scale (MPSS, 33, 35). The items included were irritable, restless, tense, anxious, 
happy, stressed, depressed, hungry, poor concentration, and poor sleep. For each item 
participants were asked to rate ‘How you have been feeling over the past week’ on a 
five-point scale (1=not at all to 5=extremely). 
Levels of physical activity were self-reported at baseline and after one, four and 
six weeks of smoking abstinence using the Seven Day Physical Activity Recall 
Questionnaire (36). During a structured interview participants recalled episodes of
physical activity for each day during the previous week. The hours spent in five categories of activity intensity were multiplied by the assigned Metabolic Equivalent 
Task (MET) value for each category; where sleep=1 MET, light=1.5 METS, 
moderate=4 METS, hard=6 METS, and very hard=10 METS. The resulting weekly 
MET score was divided by seven to give a mean daily MET score. Hours of at least 
moderate intensity activity, hours of vigorous intensity activity (‘hard’ plus ‘very 
hard’) and days with 30 minutes or more of at least moderate intensity activity were 
also determined.
Participants in the exercise group only were asked to record their heart-rate by 
radial pulse immediately following a bout of at least moderate intensity exercise on 
each day of the week. For each individual a mean post-exercise heart-rate was 
computed for one, four and six weeks of smoking abstinence. Using the heart-rate 
reserve method for deriving heart-rate ranges (28), each participants weekly heart-
rates mean was then categorised as corresponding to a ‘light’, ‘moderate’ or 
‘vigorous’ intensity of exercise. 
At baseline clothed weight and height, without shoes, were measured on calibrated 
scales to the nearest 0.25 kg and 0.5 cm, respectively. Percentage body fat was 
estimated using a Maltron 50 khz hand-to-foot bioelectrical impedance analysis 
device (37). Further measures of weight and body fat were taken after one, four and 
six weeks of smoking abstinence.
Participants expectations for the treatment regime were reported at the end of 
visits one and two as adapted from standard protocols (38,39). Patients were asked to 
indicate their strength of agreement on a five-point scale (1=strongly disagree to 5
=strongly agree) with three statements: (i) ‘I believe that taking part in this 
programme will increase my chances of stopping smoking for good’, (ii) ‘I expect to 
enjoy taking part in this programme’, and (iii) ‘I would recommend this programme to a friend’. 
Statistical analysis
Based on the findings of Marcus and colleagues (7) it was estimated that a sample of 
300 smokers would yield 80% power (at P<.05, two-tailed) at six weeks of continuous 
smoking abstinence, to detect a difference in abstinence between the treatment and 
control groups of 45% versus 30%. Unless otherwise stated analyses were conducted 
on an intention-to-treat basis according to random assignment at visit one, with two-
tailed tests, and using SPSS version 10. The baseline characteristics of the two groups 
were compared using analysis of variance (ANOVA) and chi-squared (χ2) test. 
ANOVA and χ2 test were used to analyse differences in smoking abstinence, 
exercise levels, use of NRT, withdrawal symptoms, urges to smoke, weight, body 
mass index (BMI) and estimated body fat by treatment condition. Regression analysis 
and correlation were used to examine baseline differences between the treatment 
groups as co-variates in the analysis for smoking abstinence, tobacco withdrawal and 
exercise levels. Regression analysis was used to examine whether exercise levels at 
baseline or adherence to the exercise intervention predicted smoking abstinence.
RESULTS
Participants
Of 696 smokers screened by telephone 200 were excluded from the study, 197 
decided not to participate, and 299 were randomized to the study (Figure 1). Baseline 
characteristics are presented in Table 1. The sample was predominantly female 
(62.9%, 188/299), white (87.9%, 263/299), employed (67.2%, 201/299), and in non-
professional/managerial occupations (55.5%, 166/299). Around half the sample was married (52.5%, 157/299). The vast majority of the sample reported being at a stage of 
change for exercise of ‘contemplation’ (‘I am planning to become more active in the 
next six months’, 72.2%, 216/299). ), Whilst whilst 27.8% (83/299) reported being at 
a pre-contemplation stage (‘I have no plan to become more active in the next six 
months’). Due to the recruitment criteria none of the participants reported being at a 
stage of change for exercise of ‘preparation’, ‘action’ or ‘maintenance’. At baseline 
the exercise group was found to be younger (F= 5.2, P=.02), was more likely to report 
being in a ‘contemplation’ rather than a ‘pre-contemplation' stage of change for 
exercise (F=7.0, P=.0009; exercise group: contemplation=77.9%, 120/154; control 
group: contemplation=66.2%, 96/145) and gave higher ratings for the MPSS items of 
restlessness and poor sleep when compared with the controls (F=13.4, P<.001; F=5.6, 
P=.02, respectively). There were no other baseline differences between the two 
groups.
Adherence to treatment regime
The data for adherence to the exercise regimen (Table 2) was analysed exclusively for 
those abstinent from smoking through to the final visit, using ANOVAs with planned 
comparisons unless stated otherwise. Reports of hours of moderate or vigorous 
exercise were significantly higher for the exercise group than for the controls (all at P
<.001) for baseline compared to one week (F=31.0), four weeks (F=14.1), and six 
weeks of abstinence (F=17.9). 
The exercise group reported significantly more hours of vigorous intensity 
exercise than the controls after four weeks of smoking abstinence (Mann-Whitney, Ζ=
2.7, P<.01), but not after one or six weeks of abstinence. Total METS per day were 
higher for the exercise group than for the controls for baseline compared to one week (F=21.0, P<.001), four weeks (F=19.9, P<.001), and six weeks of abstinence (F=7.1, 
P=.009). The exercise group reported more days with 30 minutes of moderate or 
vigorous exercise for baseline compared with one, four and six weeks of abstinence, 
(F=35.1; F=22.0; F=18.8, respectively, all at P<.001). By the final visit 23.0% (14/61) 
of the exercise group and 7.1% (4/56) of the control group reported at least five days 
of 30 minutes of moderate or vigorous exercise. 
Differences at baseline between the treatment groups were examined as co-
variates in the analysis for changes in reports of hours of exercise between baseline 
and one week of smoking abstinence. Regression analysis showed that being in a 
more advanced stage of change for exercise predicted reports of a greater increase in 
exercise (Beta=0.186, P=0.009). Other baseline differences were not found to be 
related to exercise adherence at this time. Using a forced entry multiple regression 
analysis, controlling for the variable stage of change for exercise, treatment group 
remained significant as a predictor of increases in hours of exercise at week one.
Following one, four and six weeks of smoking abstinence the percentage of 
participants in the exercise group having a mean post-exercise heart-rate 
corresponding to at least a moderate intensity were 61.7% (50/81), 68.9% (31/45), and 
82.3% (28/34), respectively. At both baseline and at the final visit the most frequently 
reported mode of exercise was walking, both for the exercise group (50.7% (99/195); 
73.3% (33/45), respectively) and for the controls (53.1% (51/96); 52.9% (18/34), 
respectively).
Following one and six weeks of smoking abstinence the vast majority of 
participants reported using NRT (90%, 162/180; 67%, 75/117, respectively). A chi-
squared test showed no significant differences in NRT use for the exercise group 
versus the controls at any measurement point. Following one week of abstinence 87% (141/162) of NRT users reported using the transdermal nicotine patch. Of these 64.5% 
(91/141) reported using the 15mg patch, 14.9% (21/141) the 21mg patch, and 20.6% 
(29/141) the 10mg patch. ANOVAs revealed no difference in expectations for the 
treatment regimen between the exercise and control groups at either visits one or two.
Smoking outcome
Six weeks following their quit day 39.6 % (61/154) of exercise participants and 38.6% 
(56/145) of controls were continually abstinent from smoking (Table 3a, 95% 
Confidence Interval, -10.1 to 12.1 for differences between groups). A χ2 test did not 
reveal any significant differences between the treatment groups for rates of continuous 
abstinence at any measurement point. When examining females and males separately 
a χ2 test did not show any significant differences between the treatment groups for 
smoking abstinence at any measurement point. For females the six week abstinence 
rates for the exercise and control groups were 43.8% (42/96) versus 39.1% (36/92), 
for males it was 32.8% (19/58) versus 37.7% (20/53). 
Attendance at the quit day visit was slightly, though not significantly, higher for 
the control group than for the exercise group (89% (129/145) versus 83.1% (128/154), 
respectively); thus reducing the chance of finding a significant effect for the exercise 
intervention. When examining smoking abstinence rates exclusively for those 
attending their quit day (Table 3b) a χ2 test revealed higher rates of abstinence for the 
exercise group compared with the controls after both one and two weeks of abstinence 
(χ=5.2, P=.03; χ=4.9, P=.03, respectively), but not at the other measurement points. 
Regression analysis showed that neither reports of levels of exercise at baseline nor 
stage of change for exercise predicted attendance at the quit day session. This was the 
case both for the sample as a whole and also when looking at the exercise group alone.
Using regression analysis, for the sample as whole, neither reports of hours of 
moderate or vigorous intensity exercise at baseline nor reports of increases in hours of 
this exercise between baseline and one week of smoking abstinence predicted 
smoking abstinence at six weeks (OR=.93, P=.46; OR=.98, P=.79, respectively).  Nor 
did reports of hours of vigorous exercise at baseline or increases in vigorous exercise 
between baseline and one week of abstinence predict smoking abstinence at six weeks 
(OR=.65, P=.11; OR=.14, P=.14, respectively). When looking exclusively at the 
exercise group, again using regression analysis, smoking abstinence at six weeks was 
not predicted either by reports of increases in hours of moderate or vigorous exercise 
between baseline and one week (OR=0.99, P=.89), nor by reports of increases in 
hours of vigorous exercise between baseline and one week (OR=1.09, P=.50).
Differences at baseline between the treatment conditions were examined as co-
variates in the analysis for smoking abstinence at six weeks. Logistic regression 
showed that greater age predicted higher rates of smoking abstinence, both for the 
intention-to-treat analysis and for the analysis using only those attending the quit day 
(OR=1.02, P=.03, in both cases). Baseline ratings of restlessness or poor sleep did not 
predict rates of smoking abstinence. Using a forced entry multiple logistic regression 
analysis, controlling for the variable age, treatment group remained non-significant as 
a predictor of smoking abstinence at six weeks, both for the sample as a whole and for 
those attending the quit day.
Tobacco withdrawal and urges to smoke
Separate treatment group by time ANOVAs were conducted between baseline and 
each further measurement point for each MPSS item, including all smokers abstinent 
from smoking at each measurement point. For baseline compared to one week of smoking abstinence significant group by time interactions were found (Table 4a) for 
the items of tension (F=5.0, P=.03), anxiety (F=6.5, P=.01), happiness (F=5.3, P=.03), 
and stress (F=3.3, P=.04, one-tailed). There were significant interactions for 
irritability through two weeks of abstinence relative to baseline (F=4.7, P=.03), and 
for restlessness through three weeks of abstinence relative to baseline (F=4.4, P=.04; 
Table 4b). For the happiness item ratings were higher for the exercise group than for 
the controls. In all other cases ratings were lower for the exercise group relative to the 
controls. There was no evidence of group differences for the items of depression, 
hunger, poor concentration, or poor sleep. For those abstinent through to the final visit 
ANOVAs, using planned comparisons, did not reveal any significant treatment group 
by time interactions for baseline compared to one week of abstinence for any of the 
withdrawal items. Using regression analysis there was no evidence for baseline 
differences between the treatment groups acting as confounders in the analyses for the 
withdrawal items.
ANOVAs did not reveal any between group differences for the weekly urge to 
smoke items or for a composite item combining the three separate urges to smoke 
items. This was the case both for those remaining abstinent from smoking at each 
measurement point and for those remaining abstinent throughout. For daily urges to 
smoke during the first week of abstinence ANOVAs, using planned comparisons, did 
not show any group differences, either for those remaining abstinent for one week, or 
for those abstinent throughout.
Weight and body fat gain
ANOVAs did not show any significant group by time differences between baseline 
and six weeks of smoking abstinence for weight, BMI, or estimate of percentage body 
fat. For those remaining abstinent throughout, in the exercise and control groups, the mean (SD) weight gain (kg) was 1.8 (1.9) and 2.0 (1.9), respectively; the mean 
increase in BMI was 0.6 (0.7) and 0.7 (0.7), respectively; and the mean increase in 
estimated percentage body fat was 0.7 (4.5) and 0.5 (5.2), respectively. 
CONCLUSIONS AND DISCUSSION
On an intention-to-treat basis, including a brief exercise counselling intervention in a 
smoking cessation treatment package resulted in only modest and non-significant 
increases in smoking abstinence in comparison to an equal contact control group. Nor 
was the amount of increase in exercise levels found to be related to smoking 
abstinence. However, the chance of detecting a significant difference in abstinence 
rates between the exercise and control groups was reduced by the exercise group 
having slightly lower attendance rates at the quit day visit relative to the controls. 
There were no differences in reports of expectations for the treatment regime between 
the treatment groups. Therefore the difference in attendance rates at the quit day was 
probably by chance. It is possible that the lower rates of attendance at the quit day 
session for the exercise group versus the controls was due to some of the smokers 
assigned to the exercise group being unwilling to engage in the exercise regimen, 
although neither baseline levels of exercise nor stage of change for exercise were 
shown to be related to quit day attendance. Future studies of exercise and smoking 
cessation could examine this issue further through exploring the smokers’ reasons for 
not attending their quit day visit. The finding that for those attending the quit day visit 
there were significantly higher abstinence rates for the exercise group versus the 
controls up to the first two weeks of abstinence indicates that exercise counselling 
may have some potential as an aid for smoking cessation. 
The difference in findings between the present study and the previous study (7) 
showing a positive effect of an exercise intervention on smoking cessation is likely to be partly a result of differences in the exercise intervention between the two studies. 
The previous study, by Marcus and colleagues (7), employed a 12 12-week 36 session 
supervised exercise programme. The current study used a more public health oriented 
intervention requiring only five minutes of exercise counselling plus one-two minutes 
per week of further support over seven weeks. Consequently, the smokers in the 
present study were engaged in a shorter duration of exercise programme and also 
reported lower exercise intensities compared with the Marcus study. In the current 
study only 16.4% (10/61) of the participants in the exercise group reported any 
vigorous intensity at the final treatment. , Whereas whereas in the Marcus study 
vigorous intensity exercise was adopted throughout. Reports of increases in hours of 
exercise after stopping smoking in the present study were comparable to increases 
observed in the Marcus study. However, exercise data in the current study was based 
exclusively on self-reports and it is possible that those receiving the exercise 
intervention were biased towards overestimation of their exercise levels.  Future 
studies of this type need to include more objective monitoring of physical activity 
levels; for example, through use of heart-rate monitoring or accelerometry (40,41).
Further studies are needed to determine the minimum levels of exercise and 
exercise intervention required to result in significant long-term increases in smoking 
abstinence rates; for example, receiving professional support is likely to be an 
important factor in increasing exercise adherence (42). Additionally, there is some 
evidence to suggest that abstinent smokers tend to overestimate exercise intensities 
(9), and therefore may need supervision with gauging these intensities. Therefore, an 
intervention combining exercise counselling with some supervised exercise is likely 
to increase exercise levels beyond those reported in the present study. In addition, 
studies are needed to compare the effect of different doses of exercise on smoking abstinence within the same study.
The present study is the first to combine an exercise programme with a smoking 
cessation treatment which incorporates NRT. Therefore the difference in findings 
between the present study and the Marcus study may also be partly due to the 
inclusion of NRT in the current study. NRT has previously been shown to 
approximately double smoking abstinence rates (3), and the overall abstinence rate 
reported at six weeks in the present study (39.1%) was approximately double that 
found for the exercise group in the Marcus study at eight weeks (19.4%). It is feasible 
that exercise and NRT target similar mechanisms as aids to smoking cessation, and 
therefore do not have a marked additive effect on abstinence rates. For example, 
nicotine and exercise may have some common physiological effects, such as increases 
in the release of adrenocorticoids and opioids (43,44); and some shared psychological 
effects in terms of reducing tobacco withdrawal and urges to smoke (9,45). Studies 
are needed to compare the effects on smoking abstinence of combined nicotine and 
exercise interventions with nicotine and exercise alone. Studies combining exercise 
with NRT may need to consider larger sample sizes in order to detect any modest 
effects of an exercise intervention. Additionally, exercise needs to be examined as an 
aid to smoking cessation for those who are contraindicated for NRT or who prefer not 
to use it; for example, amongst pregnant smokers. 
Although reports of exercise levels were higher for the exercise group than for the 
controls, following six weeks of smoking abstinence the exercise group gained only 
0.2kg less in body weight than the controls, a difference which did not reach statistical 
significance. This finding is in contrast with that of Marcus and colleagues (7) who 
observed that, following eight weeks of smoking cessation, those receiving an 
intensive supervised exercise programme gained 2.4kg less body weight than an equal contact control group. The lack of an effect on weight gain in the present study may 
be partly due to the lower intensities of exercise achieved in this study compared with 
the Marcus study. It may also have been related to the inclusion of NRT in the present 
study. Post-cessation weight gain is likely to be less pronounced when NRT is used 
(46). Therefore, at the outset the potential for exercise to moderate weight gain was 
reduced. Further studies are needed to determine the effect of varying doses of 
exercise on post-smoking cessation weight and body fat gain, both during NRT use 
and following discontinuation of NRT. An effective intervention for reducing post-
smoking cessation weight gain might attract smokers who fear weight gain (47), and 
could reduce relapses resulting from weight gain (48). 
This is the first study to show a more long-term, as opposed to acute, effect of 
exercise on some psychological symptoms following smoking cessation. Previously, 
the only psychological symptoms which that have been shown to reliably predict rates 
of smoking abstinence are depression and urges to smoke (49). Contrary to the 
findings of acute studies (8,9) the exercise intervention in the present study did not 
affect either of these variables. Evidence for the moderating effect of exercise on 
some psychological symptoms may increase the acceptability of exercise as an aid to 
smoking cessation. However, the reported effects of the exercise intervention on 
psychological symptoms were modest and it is possible that they were partly the result 
of attention placebo influences, whereby those in the exercise group become 
persuaded of the benefits of exercise and therefore report more psychological benefits 
than the control group. Objective validation of reports of physical activity would help 
to resolve this issue. In addition, studies are required in order to determine the effects 
of varying doses of exercise on tobacco withdrawal and on urges to smoke.
In summary, adding brief exercise counselling to a smoking cessation programme combining behavioural support and NRT resulted in only modest and non-significant 
increases in smoking abstinence. There was no evidence for the inclusion of exercise 
counselling resulting in a significant reduction in weight gain. The exercise 
intervention was shown to increase exercise levels and to moderate some 
psychological symptoms during the first few weeks of smoking abstinence. Further 
studies are needed to determine the effect of varying doses of exercise on smoking 
abstinence, and to examine the interaction between exercise and pharmaceutical aids 
to smoking cessation.
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  Characteristics Exercise Group (N=154) Mean (SD)Control 
Group (N=145) Mean (SD)   P*
Age, y   41.5 (11.1)   44.4 (11.1) 0.02
Education, y   12.8 (3.1)   12.8 (3.0) 0.89
Weight, kg  §71.8 (14.4)  §72.5 (15.4) 0.72
Body Mass Index, kg/m2  §25.4 (4.5) §25.8 (4.8) 0.46
Body fat, %  §27.9 (9.2) §§28.7 (9.2) 0.44
Fagerström Test for Nicotine Dependence score (range 0-10)      5.4 (2.1)
     5.8 (2.0) 0.11
Smoking rate, cigarettes/d   21.6 (8.8)   22.3 (9.2) 0.53
Carbon monoxide level, ppm    2 1.1 (1.5)   22.1 (10.2) 0.50
Weekly hours of exercise     1.1 (1.5)     0.9 (1.0) 0.28
Daily METs    32.7 (1.4)   32.6 (0.7) 0.47
*For differences between groups by ANOVA.            
 § Data missing for one participant      §§ Data missing for two participantsTable 2. Exercise adherence for those remaining abstinent from smoking throughout
  Exercise variable Exercise group n=61 Mean (SD)
Control group n=56 Mean (SD)
Hours of moderate or vigorous  exercise in the previous week       *                                                       
*                                                       * a. 0.9 (0.9) b. 2.6 (1.7) c. 3.0 (2.4) 
d. 3.0 (2.4) a. 0.9 (0.9) b. 0.9 (1.2) c. 1.2 (1.6) 
c. 1.2 (1.6)
Hours of vigorous exercise  in the previous week                                                       *
a. 0.1 (0.4) b. 0.2 (0.4) c. 0.3 (0.9) 
d. 0.2 (0.7) a. 0.1 (0.1) b. 0.1 (0.5) c. 0.1 (0.2) 
d. 0.1 (0.5)
 Daily METs                                                        *                                                       *                                                     
** a. 32.5 (0.8) b. 33.2 (1.1) c. 33.4 
(1.4) d. 33.4 (2.2) a. 32.6 (0.6) b. 32.5 (0.8) c. 32.6 
(0.8) d. 32.7 (0.8)
Days with 30 minutes of  moderate or vigorous exercise     *                      in the 
previous week                    *                                                      * a. 0.6 (0.9) b. 
2.5 (2.2) c. 2.4 (2.3) d. 2.6 (2.2) a. 0.7 (0.9) b. 0.7 (1.2) c. 0.7 (2.1) 
d. 1.9 (2.1)
a.: baseline;   b., c., d.: after one, four and six week of smoking abstinence, 
respectively. Significant difference relative to baseline for exercise/control 
comparison at P<.001* and at P<.05** Table 3. Continual smoking abstinence by group
(*for differences between groups by χ2)
Table 3a. On intention-to-treat basis (No./%)
 Weeks of abstinence Exercise group (n=154) Control group (n=145)
 P* 
1 98 (63.6) 82 (56.6) 0.24
2 81 (52.6) 64 (44.1) 0.16
3 73 (47.4) 62 (42.8) 0.49
4 70 (45.5) 59 (40.7) 0.42
6 61 (39.6) 56 (38.6) 0.91
Table 3b. Only for those attending their quit day (No./%)
 Weeks of abstinence Exercise group (n=129) Control group (n=128)
 P*
1 98 (76.6) 82 (63.6) 0.03
2 81 (63.3) 64 (49.6) 0.03
3 73 (57.0) 62 (48.1) 0.17
4 70 (54.7) 59 (45.7) 0.17
6 61 (47.7) 56 (43.4) 0.53Table 4. Mean (SD) ratings of tobacco withdrawal symptoms (range=1-5) 
(a.=baseline; b., c., d.=following one, two and three weeks of smoking abstinence, 
respectively.)
Table 4a. For those abstinent from smoking for one week
(P<.05 for all items for exercise/control comparison between time a. and b.)
Withdrawal  item Exercise  Group N=98 Control  Group N=82
Tension a. 2.5 (1.1) 2.5 (1.2)
Tension b. 2.4 (0.9) 2.8 (1.2)
Anxiety a. 2.4 (1.1) 2.2 (1.2)
Anxiety b. 2.1 (0.8) 2.4 (1.3)
Stress a. 2.5 (1.3) 2.4 (1.3)
Stress b. 2.3 (1.0) 2.6 (1.3)
Happiness a. 3.1 (0.9) 3.3 (1.1)
Happiness b. 3.2 (0.9) 3.1 (0.8)Table 4b. For those abstinent from smoking for two weeks (irritability, N=145) and 
three weeks (restlessness, N=135) (P<.05 for for exercise/control comparison between 
time a. and b./c. (irritability), and between time a. and b./c./d. (restlessness) )
Withdrawal item Exercise  Group Control  group
Irritability a 2.2 (1.0) 1.9 (0.7)
Irritability b 2.6 (1.1) 2.6 (1.0)
Irritability c 2.3 (0.9) 2.5 (1.1)
Restlessness a 2.6 (1.2) 2.1 (1.0)
Restlessness b 2.7 (1.1) 2.6 (0.9)
Restlessness c 2.4 (1.0) 2.4 (1.0)
Restlessness d 2.2 (1.1) 2.2 (1.0)Figure 1. Participant Flow
         